RSV continues to be the most common cause of lower respiratory tract infections worldwide. For too many infants, RSV results in serious illness. CPBF is committed to supporting education for both healthcare professionals and families about the need for RSV prevention for all infants.
The CPBF is proudly presenting a webinar to provide healthcare providers with the most up-to-date information as we enter RSV season in collaboration with the Global Alliance for Newborn Care (GLANCE) and the European Foundation for the Care of Newborn Infants (EFCNI).
Tuesday, October 24th, 2023
1 pm – 2:15 pm, Eastern Time
Includes 15-minute Q&A
Who’s it for?
Physicians, physician assistants, nurses, nurse practitioners, midwives, Public Health, parents — any healthcare provider who cares for infants and children.
Describe the burden of disease related to RSV in infants, including the epidemiology and risk factors for severe infection.
Recognize the impact of the COVID-19 pandemic on the epidemiology of RSV.
Summarize pediatric RSV prevention strategies, including the potential use of long-acting monoclonal antibodies and maternal vaccination.
Hosted by Fabiana Bacchini, Director of CPBF
Kate works full-time as a researcher for a biotech company and runs a vegetable seed farm with her husband. She is also a mom of 2 preemie girls born at 32 and 35 weeks and is a veteran parent to the NICU at Kingston Health Sciences Center. Kate had first-hand experience with RSV when her youngest baby, born at 35 weeks, required hospital admission and oxygen for RSV illness. Her daughter was later diagnosed with asthma and has been on puffers ever since.
Dr. Jesse Papenburg
Dr. Papenburg practices Pediatric Infectious Diseases and Medical Microbiology at the Montreal Children’s Hospital of the McGill University Health Centre and is an Associate Member of the Department of Epidemiology, Biostatistics and Occupational Health at McGill University.
After his specialty training, Dr. Papenburg completed a research fellowship on the molecular virology of RNA respiratory viruses at Laval University and an MSc in epidemiology at McGill. As a clinician scientist, he works on the epidemiology of viral respiratory infections and has over 130 peer-reviewed publications. He actively contributes to national and provincial guidelines on RSV immunoprophylaxis. Dr. Papenburg is also a National Advisory Committee member and the chair of NACI’s influenza working group.